Meeting with NDRC and CFDA on Regulations for Registration Fee of Pharmaceuticals and Medical Devices that is in drafting
2015-04-23 | Beijing, Shanghai
CFDA explained from the aspects: Registration Reform; fundamentals of charging the registrations; the use of registration fees, etc. Regarding industry's main concerns about 1)registration fees for import products are higher than for domestic products 2) Registration fees for imported products include costs for audits, but the CFDA will not audit overseas factory following each submission, CFDA also gave their explanation
NDRC supplemented in terms of calling for comments, timeline for this regulation to be published and enforced